The Prevalence of Coagulopathy and Associated Factors Among Adult Type II Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

References

• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81–S90. doi:10.2337/dc14-S081
   PubMed Web of Science ®Google Scholar
• Thomas C, Philipson LH. Update on diabetes classification. Med Clin. 2015;99(1):1–16. doi:10.1016/j.mcna.2014.08.015
   Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2014;37(Supplement 1):S14–S80. doi:10.2337/dc14-S014
   PubMed Web of Science ®Google Scholar
• Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. Handb Clin Neurol. 2014;126:211–222.
   PubMedGoogle Scholar
• Roglic G, Varghese C, Cowan M. Global Report on Diabetes (World Health Organization). WHO Library Cataloguing-In-Publication Data. WHO; 2016.
   Google Scholar
• Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia. 1993;36(11):1119–1125. doi:10.1007/BF00401055
   PubMed Web of Science ®Google Scholar
• Kottke-Marchant K, Corcoran G. The laboratory diagnosis of platelet disorders. Archiv Pathol Lab Med. 2002;126(2):133–146. doi:10.5858/2002-126-0133-TLDOPD
   Web of Science ®Google Scholar
• Morel O, Jesel L, Abbas M, Morel N. Prothrombotic changes in diabetes mellitus. Semin Thromb Hemost. 2013;39(5):477–488. doi:10.1055/s-0033-1343888
   PubMed Web of Science ®Google Scholar
• Kershaw G, Orellana D. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times. Semin Thromb Hemost. 2013;39(3):283–290. doi:10.1055/s-0033-1336832
   PubMed Web of Science ®Google Scholar
• Kershaw G, Jayakodi D, Dunkley S. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center. Semin Thromb Hemost. 2009;35(8):760–768. doi:10.1055/s-0029-1245108
   PubMed Web of Science ®Google Scholar
• Kershaw G, Favaloro EJ. Laboratory identification of factor inhibitors: an update. Pathology. 2012;44(4):293–302. doi:10.1097/PAT.0b013e328353254d
   Web of Science ®Google Scholar
• Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications. 2001;15(1):44–54. doi:10.1016/S1056-8727(00)00132-X
   PubMed Web of Science ®Google Scholar
• Chan P, Pan WH. Coagulation activation in type 2 diabetes mellitus: the higher coronary risk of female diabetic patients. Diabet Med. 1995;12(6):504–507. doi:10.1111/j.1464-5491.1995.tb00532.x
   Web of Science ®Google Scholar
• Mwambungu A, Kaile T, Korolova L, Kwenda J, Marimo C. Risk factors associated with hypercoagulability in type 2 diabetes mellitus patients at Ndola Central Hospital Zambia. Med J Zambia. 2014;41(2):70–80.
   Google Scholar
• Sosothikul D, Seksarn P, Lusher JM. Pediatric reference values for molecular markers in hemostasis. J Pediatr Hematol Oncol. 2007;29(1):19–22. doi:10.1097/MPH.0b013e3180308749
   Web of Science ®Google Scholar
• Shetty S, Ghosh K, Mohanty D. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer. Blood Coagulat Fibrinoly. 2003;14(5):493–497. doi:10.1097/00001721-200307000-00011
   Web of Science ®Google Scholar
• Benzon HT, Park M, McCarthy RJ, Kendall MC, Lindholm PF. Mixing studies in patients with prolonged activated partial thromboplastin time or prothrombin time. Anesthes Analges. 2019;128(6):1089–1096. doi:10.1213/ANE.0000000000003457
   Web of Science ®Google Scholar
• Horlocker TT, Vandermeulen E, Kopp SL, Gogarten W, Leffert LR, Benzon HT. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society Of Regional Anesthesia And Pain Medicine evidence-based guidelines. Region Anesthes Pain Med. 2018;43(3):263–309. doi:10.1097/AAP.0000000000000763
   PubMed Web of Science ®Google Scholar
• Smit C, Hallett TB, Lange J, Garnett G, de Wolf F. Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLoS One. 2008;3(4):e1949. doi:10.1371/journal.pone.0001949
   Web of Science ®Google Scholar
• International Diabetes Federation. IDF diabetes atlas, 9th edn. Brussels, Belgium; 2019:36–64. Available from: https://www.diabetesatlas.org. Accessed February 15, 2022.
   Google Scholar
• Colagiuri S, Guariguata L, Motala A, Ogurtsova K. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9 (th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   Web of Science ®Google Scholar
• International Diabetes Federation. IDF Africa members, Ethiopia; 2020. Available from: https://idf.org/our-network/regions-members/africa/members/9-ethiopia.html. Accessed February 15, 2022.
   Google Scholar
• Asrat D, Tesfaye G, Gedefaw L, Addisu W, Yemane T. Hemostatic abnormality and associated factors in diabetic patients at Jimma University Specialized Hospital, Jimma, Southwest Ethiopia: a comparative cross-sectional study. Ethiop J Health Sci. 2019;29(2):253–256.
   Web of Science ®Google Scholar
• Ambelu YA, Shiferaw MB, Abebe M, Enawgaw B. Prothrombin time, activated partial thromboplastin time and platelet counts of type II diabetes mellitus: a comparative study. J Diabetes Metabol Disord. 2018;17(2):117–121. doi:10.1007/s40200-018-0347-5
   Web of Science ®Google Scholar
• Population Census Commission. Summary and statistical report of the 2007 population and housing census. Population size by age and sex. 2008:314.
   Google Scholar
• Deressa T, Damtie D, Workineh M, Genetu M, Melku MJE. Anemia and thrombocytopenia in the cohort of HIV-infected adults in northwest Ethiopia: a facility-based cross-sectional study. EJIFCC. 2018;29(1):36.
   Google Scholar
• Aynalem M, Shiferaw E, Gelaw Y, Enawgaw B. Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia. Thromb J. 2021;19(1):36. doi:10.1186/s12959-021-00287-6
   Web of Science ®Google Scholar
• Keohane EM, Otto CN, Walenga JM. Rodak’s Hematology-E-Book: Clinical Principles and Applications. Elsevier Health Sciences; 2019.
   Google Scholar
• Patel SM, Gupta S, Patel MM, Mahadik JD, Patel KA, Patel AS. A study of coagulation profile in neoplastic conditions. Int J Med Sci Public Health. 2016;5(3):402–408. doi:10.5455/ijmsph.2016.1807201565
   Google Scholar
• World Health Organization. The Global Prevalence of Anemia in 2011. Geneva: WHO; 2015.
   Google Scholar
• Sultan A. Five-minute preparation of platelet-poor plasma for routine coagulation testing. East Mediterr Health J. 2010;16(2):233–236. doi:10.26719/2010.16.2.233
   Google Scholar
• Ignjatovic V. Prothrombin time/international normalized ratio. Methods Mol Biol. 2013;992:121–129.
   Google Scholar
• Ignjatovic V. Activated partial thromboplastin time. Methods Mol Biol. 2013;992:111–120.
   Google Scholar
• Miller CH. Chapter 130 - mixing studies. In: Shaz BH, Hillyer CD, Reyes Gil M, editors. Transfusion Medicine and Hemostasis. Third ed. Elsevier; 2019:783–784.
   Google Scholar
• Chotivanich K, Silamut K, Day N. Laboratory diagnosis of malaria infection. Austr J Med Sci. 2006;27(1):11.
   Google Scholar
• Owaidah T, Saleh M, Alzahrani H, et al. Prevalence of bleeding symptoms among adolescents and young adults in the capital city of Saudi Arabia. Adv Hematol. 2018;2018:1858241. doi:10.1155/2018/1858241
   PubMedGoogle Scholar
• Ephraim RK, Awuku YA, Adu P, et al. High risk of coagulopathy among type-2 diabetes mellitus clients at a municipal hospital in Ghana. Ghana Med J. 2017;51(3):101–107. doi:10.4314/gmj.v51i3.2
   Google Scholar
• Ilyas S, Waheed U, Saboor M. Coagulation abnormalities in diabetes mellitus. J Public Health Biol Sci. 2013;2(4):308–312.
   Google Scholar
• Yürekli BP, Ozcebe OI, Kirazli S, Gürlek A. Global assessment of the coagulation status in type 2 diabetes mellitus using rotation thromboelastography. Blood Coagul Fibrinolysis. 2006;17(7):545–549. doi:10.1097/01.mbc.0000245292.34150.df
   Web of Science ®Google Scholar
• Asrat D, Tesfaye G, Gedefaw L, Addisu W, Yemane T. Hemostatic abnormality and associated factors in diabetic patients at Jimma University Specialized Hospital, Jimma, Southwest Ethiopia: a Comparative Cross-sectional Study. Ethiop J Health Sci. 2019;29(2):251–258. doi:10.4314/ejhs.v29i2.12
   Web of Science ®Google Scholar
• Al-Rubeaan K, Nawaz SS, Youssef AM, Al Ghonaim M, Siddiqui K. IL-18, VCAM-1 and P-selectin as early biomarkers in normoalbuminuric type 2 diabetes patients. Biomark Med. 2019;13(6):467–478. doi:10.2217/bmm-2018-0359
   Web of Science ®Google Scholar
• Madan R, Gupt B, Saluja S, Kansra U, Tripathi B, Guliani BJ. Coagulation profile in diabetes and its association with diabetic microvascular complications. The Journal of the Association of Physicians of India. 2010;58:481–484.
   PubMedGoogle Scholar
• Grant P. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007;262(2):157–172. doi:10.1111/j.1365-2796.2007.01824.x
   PubMed Web of Science ®Google Scholar
• Ebrahim H, Asrie F, Getaneh Z. Basic coagulation profiles and platelet parameters among adult type 1 and type 2 diabetes patients at Dessie Referral Hospital, Northeast Ethiopia: comparative cross-sectional study. J Blood Med. 2021;12:33–42. doi:10.2147/JBM.S287136
   PubMed Web of Science ®Google Scholar
• Ankalayya B, Sodhi H, Modala S, Baghel M. A comparative study of coagulation time in type 2 diabetes mellitus and healthy individuals. Int J Contemp Med Res. 2016;3(11):3170–3171.
   Google Scholar
• Mariappan A, Deepa V, Nagendran R. Evaluation of coagulation profile in patients suffering with type-2 diabetes mellitus: a hospital based prospective study. Int J Clin Biochem Res. 2020;5(1):97–100.
   Google Scholar
• Karim F, Akter QS, Jahan S, et al. Coagulation impairment in type 2 diabetes mellitus. J Bangla Soc Physiol. 2015;10(1):26–29. doi:10.3329/jbsp.v10i1.24614
   Google Scholar
• Pan L, Ye Y, Wo M, et al. Clinical significance of hemostatic parameters in the prediction for type 2 diabetes mellitus and diabetic nephropathy. Dis Markers. 2018;2018:2–3. doi:10.1155/2018/5214376
   Web of Science ®Google Scholar
• Sapkota B, Shrestha SK, Poudel S. Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus. BMC Res Notes. 2013;6(1):485. doi:10.1186/1756-0500-6-485
   Google Scholar
• Alao O, Damulak D, Joseph D, Puepet F. Haemostatic profile of patients with type 2 diabetes mellitus in Northern Nigeria. Internet J Endocrinol. 2009;6(1):1–4.
   Google Scholar
• Mohammed O. Alteration in prothrombin time, INR, partial thromboplastin time and platelets in type 2 diabetes mellitus, cross-sectional study-Sudan. World J Adv Res Rev Cardiovasc Med. 2020;5(3):129–133. doi:10.30574/wjarr.2020.5.3.0065
   Google Scholar
• Thukral S, Hussain S, Bhat S, Kaur N, Reddy A. Prothrombin time (PT) and activated partial thromboplastin time (APTT) in type 2 diabetes mellitus, a case control study. Int J Contemp Med Res. 2018;5(8):H5–H9.
   Google Scholar
• Ifeanyi OE, Chukwuemeka OH, Sunday AG, Uche EC. Changes in some coagulation parameters among diabetic patients in Michael Okpara university of agriculture, Umudike, Abia state, Nigeria. World J Pharma Pharma Sci. 2014;3(4):52–61.
   Google Scholar
• Shimizu H. Thrombocytopenia in insulin-dependent diabetes mellitus. Kitakanto Med J. 1998;48(4):283–285. doi:10.2974/kmj.48.283
   Google Scholar
• Madan R, Gupt B, Saluja S, Kansra U, Tripathi B, Guliani B. Coagulation profile in diabetes and its association with diabetic microvascular complications. Assoc Physicians India. 2010;58:481–484.
   PubMedGoogle Scholar
• Soliman GZ. Abnormalities in plasma concentration of lipids and fibrinogen of Egyptian microalbuminuric NIDDM type 2 diabetic patients. Egypt J Hosp Med. 2005;21(1):66–81. doi:10.21608/ejhm.2005.18050
   Google Scholar
• Mansfield MW, Heywood DM, Grant PJ. Sex differences in coagulation and fibrinolysis in white subjects with non–insulin-dependent diabetes mellitus. Arterioscleros Thrombos Vasc Biol. 2002;16(1):160–164. doi:10.1161/01.ATV.16.1.160
   Web of Science ®Google Scholar
• Reaven GM, Scott EM, Grant PJ, et al. Hemostatic abnormalities associated with obesity and the metabolic syndrome. J Thrombos Haemost. 2005;3(5):1074–1085. doi:10.1111/j.1538-7836.2005.01277.x
   Web of Science ®Google Scholar
• Samad F, Ruf W. Inflammation, obesity, and thrombosis. Blood. 2013;122(20):3415–3422. doi:10.1182/blood-2013-05-427708
   PubMed Web of Science ®Google Scholar